Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Hepatocellular 4Sarcoma 2Radiation Injuries 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Rectal Neoplasms 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Osteosarcoma 1Meningioma 1Locally Advanced Pancreatic Cancer 1Glioma 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Radiotherapy 9Cisplatin 9pembrolizumab 6Methods 6fludarabine 4Papillomavirus Vaccines 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Early Intervention, Educational 4Cyclophosphamide 4durvalumab 3aldesleukin 3Vaccines, Synthetic 3Vaccines 3Radiosurgery 3Radiation 3Platinum 3Palliative Care 3Paclitaxel 3Nivolumab 3Gemcitabine 3Carboplatin 3Brachytherapy 3Bleomycin 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2lenvatinib 2entinostat 2aflibercept 2Trastuzumab 2Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vulvar Neoplasms × Heavy Ion Radiotherapy × Clear all
NCT05457595 2025-08-06

CYCLOPS

CNAO National Center of Oncological Hadrontherapy

Phase NA Recruiting
55 enrolled
Gynecologic

Carcinoma, Ovarian Neoplasms, Recurrence, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡